The Society for Academic Emergency Medicine Position on Ethical Relationships with the Biomedical Industry

Raquel M. Schears, Andrew Watters, Terri Schmidt, Catherine A. Marco, Gregory L. Larkin, John P. Marshall, Jon D. Mason, Brian D. McBeth, Michael J. Mello

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The Society for Academic Emergency Medicine (SAEM) intended to encourage appropriate relationships between medicine and the biomedical industry, supports ethical research to improve patient care. Physician researchers, educators, and clinicians are required to practice ethical principles of beneficence, justice, and respect for patient autonomy, and interactions with the biomedical industry also should be based on these principles. The ethical treatment of research participants must remain the primary concern of the researchers. Investigators should disclose any and all personal financial stakes or collective interests to hold or trade stock in companies pertinent to their field of study or active investigation. Investigators should ensure accurate reporting of study results because refusal to permit or delay publication of findings is unacceptable. Biomedical companies should advertise only within the scope of FDA approval and must relate clear methods and accurate results of studies.

Original languageEnglish (US)
Pages (from-to)179-181
Number of pages3
JournalAcademic Emergency Medicine
Volume14
Issue number2
DOIs
StatePublished - Feb 2007
Externally publishedYes

Fingerprint

Industry
Research Personnel
Beneficence
Social Justice
Research
Publications
Patient Care
Medicine
Physicians
Therapeutics

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Schears, R. M., Watters, A., Schmidt, T., Marco, C. A., Larkin, G. L., Marshall, J. P., ... Mello, M. J. (2007). The Society for Academic Emergency Medicine Position on Ethical Relationships with the Biomedical Industry. Academic Emergency Medicine, 14(2), 179-181. https://doi.org/10.1197/j.aem.2006.08.010

The Society for Academic Emergency Medicine Position on Ethical Relationships with the Biomedical Industry. / Schears, Raquel M.; Watters, Andrew; Schmidt, Terri; Marco, Catherine A.; Larkin, Gregory L.; Marshall, John P.; Mason, Jon D.; McBeth, Brian D.; Mello, Michael J.

In: Academic Emergency Medicine, Vol. 14, No. 2, 02.2007, p. 179-181.

Research output: Contribution to journalArticle

Schears, RM, Watters, A, Schmidt, T, Marco, CA, Larkin, GL, Marshall, JP, Mason, JD, McBeth, BD & Mello, MJ 2007, 'The Society for Academic Emergency Medicine Position on Ethical Relationships with the Biomedical Industry', Academic Emergency Medicine, vol. 14, no. 2, pp. 179-181. https://doi.org/10.1197/j.aem.2006.08.010
Schears, Raquel M. ; Watters, Andrew ; Schmidt, Terri ; Marco, Catherine A. ; Larkin, Gregory L. ; Marshall, John P. ; Mason, Jon D. ; McBeth, Brian D. ; Mello, Michael J. / The Society for Academic Emergency Medicine Position on Ethical Relationships with the Biomedical Industry. In: Academic Emergency Medicine. 2007 ; Vol. 14, No. 2. pp. 179-181.
@article{01347c5daec9456f8987a2bcf7b0bcd8,
title = "The Society for Academic Emergency Medicine Position on Ethical Relationships with the Biomedical Industry",
abstract = "The Society for Academic Emergency Medicine (SAEM) intended to encourage appropriate relationships between medicine and the biomedical industry, supports ethical research to improve patient care. Physician researchers, educators, and clinicians are required to practice ethical principles of beneficence, justice, and respect for patient autonomy, and interactions with the biomedical industry also should be based on these principles. The ethical treatment of research participants must remain the primary concern of the researchers. Investigators should disclose any and all personal financial stakes or collective interests to hold or trade stock in companies pertinent to their field of study or active investigation. Investigators should ensure accurate reporting of study results because refusal to permit or delay publication of findings is unacceptable. Biomedical companies should advertise only within the scope of FDA approval and must relate clear methods and accurate results of studies.",
author = "Schears, {Raquel M.} and Andrew Watters and Terri Schmidt and Marco, {Catherine A.} and Larkin, {Gregory L.} and Marshall, {John P.} and Mason, {Jon D.} and McBeth, {Brian D.} and Mello, {Michael J.}",
year = "2007",
month = "2",
doi = "10.1197/j.aem.2006.08.010",
language = "English (US)",
volume = "14",
pages = "179--181",
journal = "Academic Emergency Medicine",
issn = "1069-6563",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - The Society for Academic Emergency Medicine Position on Ethical Relationships with the Biomedical Industry

AU - Schears, Raquel M.

AU - Watters, Andrew

AU - Schmidt, Terri

AU - Marco, Catherine A.

AU - Larkin, Gregory L.

AU - Marshall, John P.

AU - Mason, Jon D.

AU - McBeth, Brian D.

AU - Mello, Michael J.

PY - 2007/2

Y1 - 2007/2

N2 - The Society for Academic Emergency Medicine (SAEM) intended to encourage appropriate relationships between medicine and the biomedical industry, supports ethical research to improve patient care. Physician researchers, educators, and clinicians are required to practice ethical principles of beneficence, justice, and respect for patient autonomy, and interactions with the biomedical industry also should be based on these principles. The ethical treatment of research participants must remain the primary concern of the researchers. Investigators should disclose any and all personal financial stakes or collective interests to hold or trade stock in companies pertinent to their field of study or active investigation. Investigators should ensure accurate reporting of study results because refusal to permit or delay publication of findings is unacceptable. Biomedical companies should advertise only within the scope of FDA approval and must relate clear methods and accurate results of studies.

AB - The Society for Academic Emergency Medicine (SAEM) intended to encourage appropriate relationships between medicine and the biomedical industry, supports ethical research to improve patient care. Physician researchers, educators, and clinicians are required to practice ethical principles of beneficence, justice, and respect for patient autonomy, and interactions with the biomedical industry also should be based on these principles. The ethical treatment of research participants must remain the primary concern of the researchers. Investigators should disclose any and all personal financial stakes or collective interests to hold or trade stock in companies pertinent to their field of study or active investigation. Investigators should ensure accurate reporting of study results because refusal to permit or delay publication of findings is unacceptable. Biomedical companies should advertise only within the scope of FDA approval and must relate clear methods and accurate results of studies.

UR - http://www.scopus.com/inward/record.url?scp=33846587070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846587070&partnerID=8YFLogxK

U2 - 10.1197/j.aem.2006.08.010

DO - 10.1197/j.aem.2006.08.010

M3 - Article

VL - 14

SP - 179

EP - 181

JO - Academic Emergency Medicine

JF - Academic Emergency Medicine

SN - 1069-6563

IS - 2

ER -